derstood. This pathway is distinct from now well known methylguanosine cap structure of the mRNA. Translaras/MAP kinase and Jak/Stat pathways that, among tional regulation of the ribosomal protein S16 transcript other outcomes, are involved in membrane-to-nuclear is abolished by replacement of five pyrimidines with signaling events. purines in the 5Ј UTR (Levy et al., 1991) . A short stretch Rapamycin, initially characterized as an inhibitor of of pyrimidines is also found within 139 bp of the cap G1 cell cycle progression, has recently been used to site of the 6.0 kb IGF-II transcript. Therefore, 5Ј TOP illuminate a growth factor-regulated signaling pathway tracts are candidate translational cis-regulatory elethat leads to the enhanced translation of a specific subments, TLREs (Levy et al., 1991) , that may be modulated set of mRNAs. Translation of most transcripts is unafby the rapamycin-sensitive signaling pathway. fected by the presence of rapamycin (Jefferies et al., However, there are other structural elements in the 5Ј 1994; Terada et al., 1994; Nielsen et al., 1995) . In fact, UTR of mRNAs that are known to influence translation treatment with rapamycin for 2-3 hours has only a slight initiation. It has been speculated that regulation of traninhibitory effect (15%) on overall protein synthesis (Jefscripts with long 5Ј UTRs is due to the formation of feries et al., 1994; Terada et al., 1994; Mendez et al., secondary structures that must be overcome to provide 1996). However, translation of mRNAs derived from a efficient translation initiation (Sonenberg, 1996) . In supfew genes is inhibited significantly. The gene transcripts port of this hypothesis, sequences that form stable secthus far identified as being rapamycin-sensitive include ondary structures (⌬GՅϪ64 kcal/mol) efficiently inhibit those encoding ribosomal proteins (S3, S6, S14, and translation when inserted into the 5Ј UTR (Sonenberg, S24), translation elongation factors (eEF1A and eEF2), 1996, and references therein). Examples of translaand a secreted peptide growth factor called insulin-like tionally-regulated mRNAs with long and complex 5Ј growth factor II (IGF-II). As indicated by an increased UTRs include those that encode human FGF-5, c-myc association with multiple ribosomes (polyribosomes), and ornithine decarboxylase (Sonenberg, 1996) . It is these rapamycin-sensitive transcripts are translated at possible then that formation of stable secondary struca 2-10 fold increased rate following mitogen stimulation tures within the 5Ј UTR of some transcripts, like that of (Jefferies et al., 1994; Terada et al., 1994; Nielsen et IGF-II, may confer translational regulation that is depenal., 1995) . This shift to polyribosomes occurs with a dent on rapamycin-sensitive signaling pathway. Such a concomitant decrease in the level of these mRNAs in hypothesis is supported by recent findings concerning the function of the eukaryotic initiation factor 4E (eIF4E). ribonuclear protein (mRNP) particles, a putative storage Transmembrane signaling events, involving the activation of phosphatidylinositol-3 kinase (PI3K) and phospholipase C-␥ (PLC␥), mediate activation of p70 S6 kinase (p70 S6k ) and phosphorylation of the eukaryotic initiation factor 4E (eIF4E) binding protein, 4E-BP1. Although not likely to be direct substrates for FRAP, both the activation of p70 S6k by phosphorylation and the phosphorylation of 4E-BP1 are dependent on FRAP kinase activity, an activity inhibited by the FKBP12-rapamycin complex. Activated p70
S6k phosphorylates the protein S6 in the 40S ribosomal subunit, an event that is correlated with growth factor-regulated increases in translation. Phosphorylation of 4E-BP1 prevents its inhibitory association with eIF4E. Translation initiation is catalyzed through the association of a complex of eIF4 initiation factors, including eIF4E and the RNA helicase eIF4A, with the N 7 -methylguanosine (m 7 G) cap on the mRNA. Transcripts that contain secondary structure in the 5Ј untranslated region may be especially dependent on the association of the eIF4 complex.
Regulation of Translation Initiation Components
the S6 protein in the 40S ribosomal subunit (reviewed by Chou and Blenis, 1995) . Phosphorylation of S6 has The initiation factor eIF4E is part of a complex of initiation factors (including eIF4A, eIF4B and eIF4G) that aslong been known to correlate with the increased translation observed following mitogen stimulation. Moreover, semble on the mRNA cap site and possess an RNA helicase activity. The eIF4E binds directly to the N 7 -ribosomes that contain a phosphorylated S6 protein are engaged in translation as polyribosomes a greater permethylguanosine cap structure of mRNA, providing a means for assembly of eIF4A, B, and G subunits on the centage of the time than ribosomes in which S6 is not phosphorylated. Rapamycin treatment causes the rapid 5Ј end of mRNA (for further review see Sonenberg, 1996) . Accumulation of these initiation factors on RNA inactivation of p70 S6k and the dephosphorylation of S6 in vivo (reviewed by Chou and Blenis, 1995) . However, is speculated to unwind secondary structures in the 5Ј untranslated regions of mRNA and thereby allow effisince rapamycin does not affect translation generally but rather significantly inhibits only the translation of a cient translation initiation (Sonenberg, 1996) . Two phosphoproteins that are currently thought to be involved in subset of mRNAs, the role of S6 phosphorylation appears not to be a general requirement for translation. the regulation of this complex of factors are the eIF4E binding proteins, 4E-BP1 and 4E-BP2. When in the deOn these lines, it has been speculated that S6 phosphorylation is involved in the regulated translation of mRNAs phosphorylated form, 4E-BPs bind directly to eIF4E and competitively inhibit association of eIF4G with eIF4E, an that contain 5Ј TOP elements (Jefferies et al., 1994; Terada et al., 1994) . effect that is implied to prevent the assembly of the helicase complex on mRNA (for further review see SoAlthough together these studies can be constructed into attractive models, a great deal of research into the nenberg, 1996). Growth factors are known to stimulate the phosphorylation of 4E-BP1 and cause its dissociarole of S6 and 4E-BP phosphorylation in translation regulation is still required. For example, it has been sugtion from eIF4E ( Figure 1) . Recently, two groups have reported that rapamycin potently inhibits the serumgested that eIF4E is necessary for cap-dependent translation, a process that involves the translation of most induced phosphorylation of 4E-BP1 (Beretta et al., 1996 and references therein). Consistent with the inability of eukaryotic mRNA. Furthermore, the relationship between secondary structure and 4E-BPs as well as that rapamycin to inhibit activation of MAP kinase and rsk, this phosphorylation is independent of the ras/MAP kibetween 5Ј TOP elements and S6 phosphorylation are preliminary models that are currently under research. It nase pathway (von Manteuffel et al., 1996) . Thus, the translational events that are dependent on the rapais not known whether regulation through these elements, or ones that have yet to be identified, may funcmycin-sensitive signaling pathway may be regulated in part through the phosphorylation of 4E-BPs. tion in a rapamycin-sensitive pathway or whether the storage and removal of mRNAs from RNP particles may However, 4E-BP1 is not the only connection between the rapamycin-sensitive signaling pathway and translaalso play a role. Finally, it is possible that there are other rapamycin-sensitive factors that are involved in tional regulation. Another rapamycin-sensitive mediator of signaling pathways stimulated by growth factors is the translation of the rapamycin-sensitive mRNAs described earlier in this review. Nevertheless, the observed the serine/threonine kinase p70 S6k . Phosphorylation and activation of this kinase leads to the phosphorylation of effects of rapamycin on both translation and on factors such as 4EBP1 and p70 S6k describes a signaling pathway to regulate G1 progression through a translational mechanism (Barbet et al., 1996) . Although little is known of that emanates from growth factor receptors and leads how this regulation occurs, cell cycle progression in S. to translational control. Since rapamycin is a specific cerevisiae does not appear to require the phosphorylainhibitor of this pathway, the molecule rapamycin inhibtion of S6 since mutation of the phosphorylation sites its must in some way regulate each of these growth in the yeast S6 protein (S10) does not hinder proliferation factor-stimulated effects.
( Johnson and Warner, 1987) . It may be that S6 phosphor-A Growth Factor Regulated Signaling ylation functions differently in yeast than in mammals, Pathway for Translational Control since a heat shock stimulus has opposite effects on the The inhibitory effects of rapamycin on cell cycle progresphosphorylation state of S6 in these cells. sion and translation are contingent first upon an associaRecent studies have shown that regulated translation tion of rapamycin with the intracellular protein FKBP12 functions in modulating the activity of cyclin-dependent (reviewed by Chou and Blenis, 1995) . It is now known kinases in mammalian cells. It has recently been rethat formation of this FKBP12-rapamycin complex proported that the change in expression of the cyclinvides a high affinity inhibitor of a 289 kd protein termed dependent kinase inhibitor p27 KIP1 following treatment FRAP or RAFT1 (for FKBP12-rapamycin associated prowith PDGF or lovastatin is mediated through an altered tein or rapamycin and FKBP12 target, respectively).
rate of translation of the encoding mRNA (Agrawal et FRAP is a member of a newly discovered family of phosal., 1996; Hengst and Reed, 1996) . Since the mitogenphatidylinositol kinases-related kinases (PIK-related kistimulated activity of cyclin-dependent kinases is sensinases) involved in events ranging from cell cycle regtive to rapamycin treatment (Nourse et al., 1994 , and ulation in response to stress to DNA recombination references therein), it is possible that FRAP is on the (reviewed by Keith and Schreiber, 1995) . Although the pathway to the regulated translation of cyclin-depenbiochemical regulation and function of FRAP is not comdent kinase inhibitors. Consistent with this model, treatpletely understood, FRAP has an intrinsic protein kinase ment of T lymphocytes with interleukin-2 modulates the activity as evidenced by its ability to autophosphorylate levels of the cyclin-dependent kinase inhibitors p21 CIP1 on a serine residue in vitro (Brown, et al., 1995) . Furtherand p27 KIP1 in a rapamycin-sensitive fashion (Nourse et more, FRAP has recently been shown to regulate p70 S6k al., 1994). In the case of p21 CIP1 , this regulation occurs activation in vivo in a manner that is dependent on both without alteration of the levels of the encoding mRNA. the kinase activity of FRAP and on an N-terminal domain It will be important to determine if the effect of rapamycin (Brown et al., 1995) . As implied by rapamycin-sensitivity, on p21 CIP1 and p27 KIP1 expression is through regulated it is likely that 4E-BP1 phosphorylation is also regulated translation, thus placing p21 CIP1 and p27 KIP1 among the by FRAP. No interaction with or phosphorylation of other specific rapamycin-sensitive transcripts. Identifip70
S6k or 4E-BP1 by FRAP has been observed, suggestcation of the elements within 5Ј UTRs of the rapamycining the existence of as yet unidentified components of sensitive transcripts and discovery of other intermediate this pathway. These studies suggest a role for FRAP in molecules involved in this signaling pathway will be necthe pathway leading to the phosphorylation of both S6 essary to provide a complete link between growth factor and 4E-BP1 and to the regulated translation of a subset signaling and the activation of cyclin-dependent kiof mRNA transcripts.
nases. Early signaling events that are involved in p70 S6k and Feedback Regulation of Translation by Inhibitors 4E-BP1 regulation have been further elucidated through of Translation Elongation the use of a potent inhibitor of phosphatidylinositolGrowth factors however are not the only mechanism 3-kinase (PI3K), wortmannin (Chou and Blenis, 1995) . available to activate this rapamycin-sensitve signaling Treatment of cells with wortmannin prevents the growth pathway. It has been known for over 20 years that small factor-regulated increase in p70
S6k activity (Chou and molecule inhibitors of protein translation, like cyclohexiBlenis, 1995) and 4E-BP1 phosphorylation (von Manmide and puromycin, also cause the phosphorylation of teuffel et al., 1996) . In addition, evidence in support of S6 in vivo (Gressner and Wool, 1974) . More recently, PI3K as an upstream regulator of p70
S6k and 4E-BP1 has anisomycin and cycloheximide treatment have been been derived from studies using mutants of the PDGF shown to activate p70 S6k in a rapamycin-sensitive fashreceptor and of IRS-1, respectively (Mendez et al., 1996;  ion (references within Nielsen et al., 1995, and Chou and reviewed by Chou and Blenis, 1995) . Although it is not Blenis, 1995) and cause the phosphorylation of 4E-BP1 currently clear how the signal is propagated from PI3K (von Manteuffel et al., 1996) . Interestingly, treatment of to p70 S6k and 4E-BP1, FRAP does not appear to be chick embryo fibroblasts with cycloheximide at concenupstream of PI3K (Chou and Blenis, 1995) . In addition, trations that only partially inhibit elongation causes an phospholipase C-␥ (PLC␥) and the protein kinases PKC overall increase in the rate of synthesis of ribosomal and Akt have been implied to have some function in this proteins, some of the same proteins whose translation is pathway (Chou and Blenis, 1995) . Thus, the outline of a activated by growth factors and inhibited by rapamycin growth factors-regulated signaling pathway that leads (Ignotz et al., 1981) . In addition, the small molecule anito translational control is beginning to emerge and is somycin causes a 2-3 fold increase in the association distinct from the now familiar MAP kinase pathway (Figof eEF1A and IGF-II (6.0 kb variant) mRNAs with polyriure 1).
bosomes (Nielsen et al., 1995) . Overall, these results It is possible rapamycin's effects on translation are suggest that, in addition to a pathway initiated by growth responsible for its ability to inhibit G1 cell cycle progresfactor receptors, an intracellular signaling cascade emasion. In accord with such a hypothesis, the S. cerevisiae nating from the protein synthesis machinery itself induces translational events that are rapamycin-sensitive. homologs of FRAP, TOR1, and TOR2, are now thought Barbet, N.C., Schneider, U., Helliwell, S.B., Stanfield, I., Tuite, M.F., and Hall, M.N. (1996) . Mol. Biol. Cell 7, 25-42. Beretta, L., Gingras, A.-C., Svitkin, Y.V., Hall, M., and Sonenberg, N. (1996) . EMBO J. 15, [658] [659] [660] [661] [662] [663] [664] Brown, E.J., Beal, P.A., Keith, C.T., Chen, J., Shin, T.B., and Schreiber, S.L. (1995) . Nature 377, 441-446. Chou, M.M., and Blenis, J. (1995) . Cur. Opin. Cell Biol. 7, 806-814. Gressner, A.M., and Wool, I.G. (1974 ). Biochem. and Biophys. Res. Com. 60, 1482 -1490 . Hengst, L., and Reed, S. (1996 . Science 271, 1861-1864.
Ignotz, G.G., Hokari, S., DePhilip, R.M., Tsukada, K., and Lieberman, I. (1981) . Biochemistry 20, 2550-2558. Figure 2. way propagated by another member of the PIK-related von Manteuffel, S.R., Gingras, A.-C., Sonenberg, N., and Thomas, G. (1996) . Proc. Natl. Acad. Sci. USA 93, [4076] [4077] [4078] [4079] [4080] kinase family, MEC1. MEC1 is an S. cerevisiae gene product that is homologous to FRAP and regulates the cell cycle progression in response to conditions that retard DNA synthesis, such as depletion of deoxyribonucleotides (Sanchez et al., 1996 , and references therein). Other than regulating S phase progression, MEC1 responds to the depletion of deoxyribonucleotides (via hydroxyurea treatment) by mediating a signaling pathway that induces the expression of ribonucleotide reductase, an enzyme involved in the biosynthesis of deoxyribonucleic acids. This signaling pathway, which is just beginning to be understood, is strikingly similar to the activation of the FRAP/p70 S6k pathway that is initiated by inhibitors of translation elongation (Figure 2) . In analogy to the MEC1-mediated upregulation of ribonucleotide reductase in response to depletion of deoxyribonucleotides, FRAP appears to mediate an increase in the translation of ribosomal proteins in response to inhibition of the 60S ribosomal subunit. Thus, in addition to an involvement in growth factor-regulated events, these feedback pathways suggest a sensory role for FRAP analogous to that of MEC1. The implication of FRAP in this process and in the control of translation and cell cycle progression provides opportunities for further research in areas that are just beginning to emerge.
